Article
Cystatin-C versus Creatinine-Based eGFR in Bardet-Biedl Syndrome: Implications for Chronic Kidney Disease Detection
2026-07-27
Abstract excerpt
<title>Abstract</title> <p> Background Bardet–Biedl syndrome (BBS) is a rare multisystem ciliopathy with significant kidney involvement. Reliance on serum creatinine for estimating glomerular filtration rate (GFR) may underestimate impairment for children with reduced muscle mass or obesity. Cystatin-C is an alternative marker less affected by muscle mass, but its role in BBS surveillance remains under-explored...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- dcc25352-74a1-59a9-a3c5-ed0ee6cb243f
- DOI
- 10.21203/rs.3.rs-10403020/v1
